Ciclopoli gegen Nagelpilz from Almirall S.A. - targeted lacquer for stubborn nail fungus

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-23, 08:56. Details in the imprint.

When you brush Ciclopoli gegen Nagelpilz onto a thickened, yellowish toenail, the clear lacquer leaves a thin, slightly shiny film that tightens as it dries and barely catches on a sock. This everyday detail is exactly what Almirall targets with its once-daily antifungal lacquer.

How Ciclopoli works on the nail

Ciclopoli gegen Nagelpilz is a medicated nail lacquer with 8% ciclopirox, formulated to treat mild to moderate fungal infections of the fingernails and toenails. The active ingredient is designed to penetrate the hard keratin of the nail plate and reach the nail bed, where dermatophytes and yeasts often sit.

According to Almirall’s German dermatology unit, the formulation uses a so-called hydroxypropyl chitosan (HPCH) technology that improves nail permeability and helps the lacquer bind to the nail surface after application. That binding is meant to keep the drug in contact with the infected area for many hours without the need for occlusive plasters or aggressive filing.

Routine for patients and doctors

In daily practice, dermatologists like Professor Thomas Luger in Münster have highlighted how adherence makes or breaks nail fungus therapy, because nails grow slowly and full treatment can take six to twelve months for a big toenail. A once-daily lacquer that does not require pre-treatment with a nail file is therefore attractive to patients who already struggle with complex routines.

Patients are typically instructed to apply Ciclopoli in the evening to clean, dry nails, covering the entire nail surface and, if possible, the underside of the free nail edge. The next evening, any residual film is simply washed off with water and soap before fresh lacquer is applied, which feels less harsh on the surrounding skin than older solvent-heavy products.

Where the lacquer convinces

On the shelf, Ciclopoli gegen Nagelpilz stands out as a pharmacy-only product positioned for cases where the nail matrix is not yet fully destroyed. The small bottle and integrated brush make the application feel similar to cosmetic nail care, which lowers the threshold for long-term use.

Clinical studies cited by Almirall show that ciclopirox lacquer can reach mycological cure rates that are competitive with older amorolfine formulations in mild to moderate disease, provided patients stick to therapy over many months. This consistent efficacy profile has made the product a reference option for early-stage onychomycosis in several European markets.

Limitations patients should know

However, Ciclopoli gegen Nagelpilz is not a miracle shortcut. In severe cases with extensive nail matrix involvement, guidelines usually recommend systemic oral antifungals such as terbinafine, potentially combined with topical lacquer, and this still applies when using ciclopirox-based therapy.

Patients with diabetes, peripheral vascular disease, or heavily distorted nails are generally advised to seek a dermatologist or podiatrist before relying solely on a lacquer. In everyday life, some users can also find the nightly routine tedious once the initial motivation fades, and incomplete courses are a common reason for relapse.

Place in Almirall’s dermatology strategy

Under CEO Carlos Gallardo Piqué, Almirall has doubled down on medical dermatology as a core growth pillar, moving from traditional prescription brands into a broader skin-health portfolio that also touches pharmacy self-medication. Ciclopoli gegen Nagelpilz fits into this strategy as a relatively low-cost, chronic-use product with strong pharmacy visibility.

While the company is better known globally for prescription treatments such as its psoriasis and actinic keratosis therapies, nail fungus affects a large, often undertreated population, especially older adults. For investors, that means a long-tail revenue stream that is less volatile than patent-protected blockbusters, even if each individual pack sells for a modest price.

Stock angle in one sentence

Almirall shares (ISIN ES0157097017) trade on the Spanish stock exchange in Madrid, where dermatology brands like Ciclopoli gegen Nagelpilz contribute to a diversified revenue base that healthcare-focused investors monitor alongside the company’s prescription pipeline.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.